Swan-Ganz catheter for cardiogenic shock after heart attack
Part of Heart & circulation clinical trials.
This study tests whether a special catheter (Swan-Ganz) placed in the heart's blood vessels helps doctors better manage fluids and medications for people in cardiogenic shock after a heart attack. It aims to improve blood flow to vital organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cardiogenic shock from a recent heart attack, meaning your blood pressure is very low for at least 30 minutes or you need medicine to keep it up.
- You have signs that your organs aren't getting enough blood, like confusion, low urine output, cold skin, or high blood lactate levels.
- You do not have a neck infection or a history of neck radiation that would prevent catheter placement.
- You do not have a bleeding disorder (INR >1.5 or low platelets) or end-stage diseases like advanced cancer, advanced HIV, or severe liver cirrhosis.
- You do not have a heart defect present at birth or a hole between heart chambers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a special pressure-monitoring tube in the heart’s main artery (a pulmonary artery catheter) helps people who are in cardiogenic shock from weak heart pumping. If you qualify, the goal is to improve how doctors monitor and treat this dangerous, fast-moving condition.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
This trial tests whether a temporary heart pump (called an intra-aortic balloon pump, or IABP) helps people who have a hole in the heart after a heart attack. The pump is placed in the main artery to help your heart pump blood more effectively.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
This study looks at how well a temporary heart pump helps people who have had a heart attack complicated by cardiogenic shock. The pump supports the heart while doctors restore blood flow, which may improve recovery.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.